Logo
UNAUDITED INTERIM
RESULTS
for the six months ended
31 December
2022
RE-IMAGINING
THE HEALTHCARE
SYSTEM

Summarised consolidated statement of changes in equity

EXCEL DOWNLOAD
   Unaudited 
six months 
ended 31  December 
2022 
R'000
 
Unaudited 
six months 
ended 
31 December 
2021 
R'000 
Audited 
year ended 
30 June 
2022 
R'000 
Balance at beginning of the period  3 445 885  3 255 724  3 255 724 
Issue of share capital*  30  10  17 
Share premium*  14 156  6 172  10 180 
Vested Share-based awards*  (14 186) (6 723) (10 197)
Share-based awards reserve  5 970  2 533  13 860 
Distributions to shareholders  (98 972) (97 426) (195 137)
Net profit for the period  127 827  155 495  315 341 
Profit attributable to minorities  69 272  79 837  167 900 
Changes in ownership interests in subsidiaries that do not result in loss of control  (83 560) —  (13 023)
Distributions to non-controlling interests  (51 177) (48 337) (98 780)
Balance at end of the period  3 415 245  3 347 285  3 445 885 
* During the period ending December 2022, 3 026 662 shares vested as follows:
 
663 342 shares were exercised at the weighted average price of R5.20 and the grant date price was R6.20;
943 333 shares were exercised at the weighted average price of R5.20 and the grant date price was R5.50; and
1 419 987 shares were exercised at the weighted average price of R5.20 and the grant date price was R3.30

At the end of the December 2022 period, 13 863 329 shares were outstanding for the incentive share scheme.
The fair value of the shares granted was determined by obtaining the share price as traded on the JSE.